Use of 3, 11b-cis-dihydrotetrabenazine in the treatment of multiple sclerosis and autoimmune myelitis

Details for Australian Patent Application No. 2008320603 (hide)

Owner Biovail Laboratories International (Barbados) SRL

Inventors Duffield, Andrew John

Agent Davies Collison Cave

Pub. Number AU-A-2008320603

PCT Pub. Number WO2009/056885

Priority 0721669.0 02.11.07 GB

Filing date 29 October 2008

Wipo publication date 7 May 2009

International Classifications

A61K 31/4745 (2006.01)

A61P 25/28 (2006.01) Drugs for disorders of the nervous system

Event Publications

13 May 2010 PCT application entered the National Phase

  PCT publication WO2009/056885 Priority application(s): WO2009/056885

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2008320611-Process for bleaching pulp

2008320602-Technology enterprise management apparatus and method therefor